A meta-analytic review of polyunsaturated fatty acid compositions in patients with depression

Biological Psychiatry

Volumn 68, Issue 2, 2010, Pages 140-147

  Lin, Pao Yen ^a   Huang, Shih Yi ^b   Su, Kuan Pin ^b,c  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Arachidonic acid; depression; docosahexaenoic acid; eicosapentaenoic acid; omega 3; polyunsaturated fatty acids

Indexed keywords

ANTIDEPRESSANT AGENT; ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PHOSPHOLIPID; POLYUNSATURATED FATTY ACID;

ARTICLE; CLINICAL TRIAL; DEPRESSION; HUMAN; LIPID BLOOD LEVEL; LIPID COMPOSITION; META ANALYSIS; PATHOGENESIS; PHOSPHOLIPID BLOOD LEVEL; PREVALENCE; PRIORITY JOURNAL; SYSTEMATIC REVIEW; BLOOD;

DEPRESSIVE DISORDER; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; HUMANS;

EID: 77954204762     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2010.03.018     Document Type: Article

References (73)

1. The World Health Report Mental Health: News Understanding News Hope 2001 World Health Organization Geneva
2. C.J. Murray, and A.D. Lopez Alternative projections of mortality and disability by cause 19902020: Global Burden of Disease Study Lancet 349 1997 1498 1504
3. K.P. Su Biological mechanism of antidepressant effect of Omega-3 fatty acids: How does fish oil act as a "mindbody interface?" Neuro Signals 17 2009 144 152
4. D.F. Horrobin, and C.N. Bennett Depression and bipolar disorder: Relationships to impaired fatty acid and phospholipid metabolism and to diabetes, cardiovascular disease, immunological abnormalities, cancer, ageing and osteoporosis Possible candidate genes Prostaglandins Leukot Essent Fatty Acids 60 1999 217 234
5. D.F. Horrobin Phospholipid metabolism and depression: The possible roles of phospholipase A2 and coenzyme A-independent transacylase Hum Psychopharmacol 16 2001 45 52
6. K.P. Su, W.W. Shen, and S.Y. Huang Effects of polyunsaturated fatty acids on psychiatric disorders Am J Clin Nutr 72 2000 1241
7. A. Tanskanen, J.R. Hibbeln, J. Tuomilehto, A. Uutela, A. Haukkala, and H. Viinamaki Fish consumption and depressive symptoms in the general population in Finland Psychiatr Serv 52 2001 529 531
8. A. Tanskanen, J.R. Hibbeln, J. Hintikka, K. Haatainen, K. Honkalampi, and H. Viinamaki Fish consumption, depression, and suicidality in a general population Arch Gen Psychiatry 58 2001 512 513
9. J.R. Hibbeln Fish consumption and major depression Lancet 351 1998 1213
10. L.B. Marangell, J.M. Martinez, H.A. Zboyan, B. Kertz, H.F. Kim, and L.J. Puryear A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression Am J Psychiatry 160 2003 996 998
11. K.M. Silvers, C.C. Woolley, F.C. Hamilton, P.M. Watts, and R.A. Watson Randomised double-blind placebo-controlled trial of fish oil in the treatment of depression Prostaglandins Leukot Essent Fatty Acids 72 2005 211 218
12. K.P. Su, S.Y. Huang, C.C. Chiu, and W.W. Shen Omega-3 fatty acids in major depressive disorder A preliminary double-blind, placebo-controlled trial Eur Neuropsychopharmacol 13 2003 267 271
13. B. Nemets, Z. Stahl, and R.H. Belmaker Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder Am J Psychiatry 159 2002 477 479
14. M. Peet, and D.F. Horrobin A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs Arch Gen Psychiatry 59 2002 913 919
15. S. Frangou, M. Lewis, and P. McCrone Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: Randomised double-blind placebo-controlled study Br J Psychiatry 188 2006 46 50
16. H. Nemets, B. Nemets, A. Apter, Z. Bracha, and R.H. Belmaker Omega-3 treatment of childhood depression: A controlled, double-blind pilot study Am J Psychiatry 163 2006 1098 1100
17. S. Jazayeri, M. Tehrani-Doost, S.A. Keshavarz, M. Hosseini, A. Djazayery, and H. Amini Comparison of therapeutic effects of omega-3 fatty acid eicosapentaenoic acid and fluoxetine, separately and in combination, in major depressive disorder Aust N Z J Psychiatry 42 2008 192 198
18. C.C. Chiu, S.Y. Huang, W.W. Shen, and K.P. Su Omega-3 fatty acids for depression in pregnancy Am J Psychiatry 160 2003 385
19. K.P. Su, S.Y. Huang, T.H. Chiu, K.C. Huang, C.L. Huang, H.C. Chang, and C.M. Pariante Omega-3 fatty acids for major depressive disorder during pregnancy: Results from a randomized, double-blind, placebo-controlled trial J Clin Psychiatry 69 2008 644 651
20. T.M. da Silva, R.P. Munhoz, C. Alvarez, K. Naliwaiko, A. Kiss, R. Andreatini, and A.C. Ferraz Depression in Parkinson's disease: A double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation J Affect Disord 111 2008 351 359
21. J.R. Hibbeln, and N. Salem Jr Dietary polyunsaturated fatty acids and depression: When cholesterol does not satisfy Am J Clin Nutr 62 1995 1 9
22. W.E. Lands Biochemistry and physiology of n-3 fatty acids FASEB J 6 1992 2530 2536
23. R.K. McNamara, and S.E. Carlson Role of omega-3 fatty acids in brain development and function: Potential implications for the pathogenesis and prevention of psychopathology Prostaglandins Leukot Essent Fatty Acids 75 2006 329 349
24. S. Chalon Omega-3 fatty acids and monoamine neurotransmission Prostaglandins Leukot Essent Fatty Acids 75 2006 259 269
25. A.A. Farooqui, W.Y. Ong, and L.A. Horrocks Inhibitors of brain phospholipase A2 activity: Their neuropharmacological effects and therapeutic importance for the treatment of neurologic disorders Pharmacol Rev 58 2006 591 620
26. C. Song, B.E. Leonard, and D.F. Horrobin Dietary ethyl-eicosapentaenoic acid but not soybean oil reverses central interleukin-1-induced changes in behavior, corticosterone and immune response in rats Stress 7 2004 43 54
27. C. Song, A.G. Phillips, B.E. Leonard, and D.F. Horrobin Ethyl-eicosapentaenoic acid ingestion prevents corticosterone-mediated memory impairment induced by central administration of interleukin-1beta in rats Mol Psychiatry 9 2004 630 638
28. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 4th ed. 1994 American Psychiatric Association Washington, DC
29. A.M. Fehily, O.A.M. Bowey, F.R. Ellis, and B.W. Meade Plasma and erythrocyte membrane long chain polyunsaturated fatty acids in endogenous depression Neurochem Int 3 1981 37 42
30. M. Maes, R. Smith, A. Christophe, P. Cosyns, R. Desnyder, and H. Meltzer Fatty acid composition in major depression: Decreased omega 3 fractions in cholesteryl esters and increased C20: 4 Omega 6/C20:5 omega 3 ratio in cholesteryl esters and phospholipids J Affect Disord 38 1996 35 46
31. P.B. Adams, S. Lawson, A. Sanigorski, and A.J. Sinclair Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression Lipids 31 suppl 1996 S157 S161
32. R. Edwards, M. Peet, J. Shay, and D. Horrobin Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients J Affect Disord 48 1998 149 155 (Pubitemid 28244216)
33. M. Peet, B. Murphy, J. Shay, and D. Horrobin Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients Biol Psychiatry 43 1998 315 319 (Pubitemid 28137622)
34. M. Maes, A. Christophe, J. Delanghe, C. Altamura, H. Neels, and H.Y. Meltzer Lowered omega3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients Psychiatry Res 85 1999 275 291
35. S.R. De Vriese, A.B. Christophe, and M. Maes Lowered serum n-3 polyunsaturated fatty acid (PUFA) levels predict the occurrence of postpartum depression: Further evidence that lowered n-PUFAs are related to major depression Life Sci 73 2003 3181 3187
36. H. Tiemeier, H.R. van Tuijl, A. Hofman, A.J. Kiliaan, and M.M. Breteler Plasma fatty acid composition and depression are associated in the elderly: The Rotterdam Study Am J Clin Nutr 78 2003 40 46
37. C.C. Chiu, S.Y. Huang, K.P. Su, M.L. Lu, M.C. Huang, C.C. Chen, and W.W. Shen Polyunsaturated fatty acid deficit in patients with bipolar mania Eur Neuropsychopharmacol 13 2003 99 103
38. N. Frasure-Smith, F. Lesperance, and P. Julien Major depression is associated with lower omega-3 fatty acid levels in patients with recent acute coronary syndromes Biol Psychiatry 55 2004 891 896
39. A. Schins, H.J. Crijns, R.J. Brummer, M. Wichers, R. Lousberg, S. Celis, and A. Honig Altered omega-3 polyunsaturated fatty acid status in depressed post-myocardial infarction patients Acta Psychiatr Scand 115 2007 35 40
40. A.A. Amin, R.A. Menon, K.J. Reid, W.S. Harris, and J.A. Spertus Acute coronary syndrome patients with depression have low blood cell membrane omega-3 fatty acid levels Psychosom Med 70 2008 856 862
41. R.L. Aupperle, D.R. Denney, S.G. Lynch, S.E. Carlson, and D.K. Sullivan Omega-3 fatty acids and multiple sclerosis: Relationship to depression J Behav Med 31 2008 127 135
42. C. Feart, E. Peuchant, L. Letenneur, C. Samieri, D. Montagnier, A. Fourrier-Reglat, and P. Barberger-Gateau Plasma eicosapentaenoic acid is inversely associated with severity of depressive symptomatology in the elderly: Data from the Bordeaux sample of the Three-City Study Am J Clin Nutr 87 2008 1156 1162
43. T. Dinan, L. Siggins, P. Scully, S. O'Brien, P. Ross, and C. Stanton Investigating the inflammatory phenotype of major depression: Focus on cytokines and polyunsaturated fatty acids J Psychiatr Res 43 2009 471 476
44. A.M. Rees, M.P. Austin, C. Owen, and G. Parker Omega-3 deficiency associated with perinatal depression: Case control study Psychiatry Res 166 2009 254 259
45. S. Riemer, M. Maes, A. Christophe, and W. Rief Lowered omega-3 PUFAs are related to major depression, but not to somatization syndrome J Affect Disord 2009
46. K.P. Su, S.Y. Huang, C.Y. Peng, H.C. Lai, C.L. Huang, and Y.C. Chen Phospholipase A2 and cyclooxygenase 2 genes influence the risk of interferon-alpha-induced depression by regulating polyunsaturated fatty acids levels Biol Psychiatry 67 2010 550 557
47. P. Green, H. Hermesh, A. Monselise, S. Marom, G. Presburger, and A. Weizman Red cell membrane omega-3 fatty acids are decreased in nondepressed patients with social anxiety disorder Eur Neuropsychopharmacol 16 2006 107 113
48. W.R. Shadish, and C.K. Haddock Combining estimates of effect size H. Cooper, L.V. Hedges, The Handbook of Research Synthesis 1994 Russell Sage Foundation New York 261 281
49. M. Egger, S.G. Davey, M. Schneider, and C. Minder Bias in meta-analysis detected by a simple, graphical test BMJ 315 1997 629 634
50. R.K. McNamara, C.G. Hahn, R. Jandacek, T. Rider, P. Tso, K.E. Stanford, and N.M. Richtand Selective deficits in the omega-3 fatty acid docosahexaenoic acid in the postmortem orbitofrontal cortex of patients with major depressive disorder Biol Psychiatry 62 2007 17 24
51. S. Delion, S. Chalon, D. Guilloteau, B. Lejeune, J.C. Besnard, and G. Durand Age-related changes in phospholipid fatty acid composition and monoaminergic neurotransmission in the hippocampus of rats fed a balanced or an n-3 polyunsaturated fatty acid-deficient diet J Lipid Res 38 1997 680 689
52. S. Delion, S. Chalon, D. Guilloteau, J.C. Besnard, and G. Durand Alpha-linolenic acid dietary deficiency alters age-related changes of dopaminergic and serotoninergic neurotransmission in the rat frontal cortex J Neurochem 66 1996 1582 1591
53. S. Delion, S. Chalon, J. Herault, D. Guilloteau, J.C. Besnard, and G. Durand Chronic dietary alpha-linolenic acid deficiency alters dopaminergic and serotonergic neurotransmission in rats J Nutr 124 1994 2466 2475
54. M. Maes, and H.Y.M. Meltzer The serotonin hypothesis of major depression F.E. Bloom, D.J. Kupfer, Psychopharmacology, the Fourth Generation of Progress 1995 Raven New York 933 941
55. M. Peet, and C. Stokes Omega-3 fatty acids in the treatment of psychiatric disorders Drugs 65 2005 1051 1059
56. M.P. Freeman, J.R. Hibbeln, K.L. Wisner, J.M. Davis, D. Mischoulon, and M. Peet Omega-3 fatty acids: Evidence basis for treatment and future research in psychiatry J Clin Psychiatry 67 2006 1954 1967
57. P.Y. Lin, and K.P. Su A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids J Clin Psychiatry 68 2007 1056 1061
58. W.S. Fenton, J. Hibbeln, and M. Knable Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia Biol Psychiatry 47 2000 8 21
59. M. Maes, and R.S. Smith Fatty acids, cytokines, and major depression Biol Psychiatry 43 1998 313 314
60. K.M. Appleton, R.C. Hayward, D. Gunnell, T.J. Peters, P.J. Rogers, D. Kessler, and A.R. Ness Effects of n-3 long-chain polyunsaturated fatty acids on depressed mood: Systematic review of published trials Am J Clin Nutr 84 2006 1308 1316
61. P.J. Rogers, K.M. Appleton, D. Kessler, T.J. Peters, D. Gunnell, and R.C. Hayward No effect of n-3 long-chain polyunsaturated fatty acid (EPA and DHA) supplementation on depressed mood and cognitive function: A randomised controlled trial Br J Nutr 99 2008 421 431
62. A. Lapillonne, J.C. Demar, V. Nannegari, and W.C. Heird The fatty acid profile of buccal cheek cell phospholipids is a noninvasive marker of long-chain polyunsaturated fatty acid status in piglets J Nutr 132 2002 2319 2323
63. M. Makrides, M.A. Neumann, R.W. Byard, K. Simmer, and R.A. Gibson Fatty acid composition of brain, retina, and erythrocytes in breast- and formula-fed infants Am J Clin Nutr 60 1994 189 194
64. W.E. Connor, M. Neuringer, and D.S. Lin Dietary effects on brain fatty acid composition: The reversibility of n-3 fatty acid deficiency and turnover of docosahexaenoic acid in the brain, erythrocytes, and plasma of rhesus monkeys J Lipid Res 31 1990 237 247
65. K.D. Stark The percentage of n-3 highly unsaturated fatty acids in total HUFA as a biomarker for omega-3 fatty acid status in tissues Lipids 43 2008 45 53
66. L.M. Arterburn, E.B. Hall, and H. Oken Distribution, interconversion, and dose response of n-3 fatty acids in humans Am J Clin Nutr 83 2006 1467S 1476S
67. J. Cao, K.A. Schwichtenberg, N.Q. Hanson, and M.Y. Tsai Incorporation and clearance of omega-3 fatty acids in erythrocyte membranes and plasma phospholipids Clin Chem 52 2006 2265 2272
68. W.S. Harris, J.V. Pottala, S.A. Sands, and P.G. Jones Comparison of the effects of fish and fish-oil capsules on the n 3 fatty acid content of blood cells and plasma phospholipids Am J Clin Nutr 86 2007 1621 1625
69. G. Mamalakis, M. Tornaritis, and A. Kafatos Depression and adipose essential polyunsaturated fatty acids Prostaglandins Leukot Essent Fatty Acids 67 2002 311 318
70. G. Mamalakis, M. Kiriakakis, G. Tsibinos, and A. Kafatos Depression and adipose polyunsaturated fatty acids in an adolescent group Prostaglandins Leukot Essent Fatty Acids 71 2004 289 294
71. G. Mamalakis, N. Kalogeropoulos, N. Andrikopoulos, C. Hatzis, D. Kromhout, J. Moschandreas, and A. Kafatos Depression and long chain n-3 fatty acids in adipose tissue in adults from Crete Eur J Clin Nutr 60 2006 882 888
72. G. Mamalakis, M. Kiriakakis, G. Tsibinos, C. Hatzis, S. Flouri, C. Mantzoros, and A. Kafatos Depression and serum adiponectin and adipose omega-3 and omega-6 fatty acids in adolescents Pharmacol Biochem Behav 85 2006 474 479
73. G. Mamalakis, M. Kiriakakis, G. Tsibinos, E. Jansen, H. Cremers, and C. Strien Lack of an association of depression with n-3 polyunsaturated fatty acids in adipose tissue and serum phospholipids in healthy adults Pharmacol Biochem Behav 89 2008 6 10